|
19 Jun 2015 |
Sandoz announces US launch of Glatopa(TM), the first generic competitor to Copaxone® 20mg
|
|
18 Jun 2015 |
Admune Announces the First-in-Human Study of Heterodimeric IL-15 (hetIL-15) with Broad Applications for Cancer Immunotherapy
|
|
18 Jun 2015 |
Derma Sciences Completes Non-Clinical Aclerastide Toxicology Program
|
|
18 Jun 2015 |
Radius Announces Positive Top-Line Data From ACTIVExtend Trial Including Combined 25 Month Results
|
|
18 Jun 2015 |
Viventia Presents Validating Evidence for Highly Differentiated De-immunized Payload for Oncology at 13th Empowered Antibodies Conference
|
|
18 Jun 2015 |
BMN 111 (vosoritide) Improves Growth Velocity in Children With Achondroplasia in Phase 2 Study
|
|
17 Jun 2015 |
Synergy Pharmaceuticals Announces Positive Results in the First Phase 3 Trial of Plecanatide in Patients with Chronic Idiopathic Constipation (CIC)
|
|
15 Jun 2015 |
Chiasma Submits New Drug Application to U.S. FDA for Octreotide Capsules in Acromegaly
|
|
15 Jun 2015 |
Genzyme Initiates Phase 1/2 Clinical Trial to Evaluate Olipudase Alfa in Pediatric Patients
|
